List of Tabuk Pharmaceuticals Executive and Leadership Team

Leadership Overview

Tabuk Pharmaceuticals has 4 executives leading key functions including strategy, marketing, finance, and executive operations.

Driven by a commitment to accessible healthcare, Tabuk Pharmaceuticals delivers quality, cost-effective generic pharmaceuticals across the MENA region, impacting major therapeutic areas and enhancing patient well-being.

Leadership Roles at Tabuk Pharmaceuticals

Chief Executive Officer - Ismail Shehada

Chief Executive Officer Office Manager - Doaa Bugis

Chief Financial Officer - Saad Stephan

Chief Marketing Officer - Hatem Reda

Ismail Shehada - Chief Executive Officer

Ismail Shehada, the Chief Executive Officer at Tabuk Pharmaceuticals, directs the overarching corporate strategy and operational execution. Shehada guides the company's expansion within regulated MENA markets, ensuring adherence to quality standards and cost-effectiveness. This leadership role involves aligning all departments toward achieving Tabuk Pharmaceuticals' mission of delivering essential medicines. Overseeing market penetration and product portfolio development, Shehada drives the company's growth in key therapeutic areas such as GI and diabetes, cardiovascular, musculoskeletal, respiratory, infection, and central nervous system pharmaceuticals. The strategic vision set by Ismail Shehada ensures Tabuk Pharmaceuticals maintains its competitive edge and commitment to public health across the region.

Doaa Bugis - Chief Executive Officer Office Manager

Doaa Bugis, the Chief Executive Officer Office Manager at Tabuk Pharmaceuticals, manages the executive office's daily operations and administrative functions. Bugis ensures seamless communication and coordination between the CEO's office and other departments, facilitating efficient workflow and decision-making processes. This role is critical for supporting the strategic initiatives spearheaded by the Chief Executive Officer. Doaa Bugis oversees scheduling, correspondence, and the preparation of essential documentation, directly contributing to the smooth execution of Tabuk Pharmaceuticals' business objectives. The effective management provided by Bugis supports the company's commitment to delivering quality, cost-effective pharmaceuticals across the MENA region.

Saad Stephan - Chief Financial Officer

Saad Stephan, the Chief Financial Officer at Tabuk Pharmaceuticals, directs all financial planning, management, and reporting activities. Stephan ensures robust fiscal health and optimizes financial performance to support the company's mission of delivering cost-effective pharmaceuticals. This critical role involves managing budgets, overseeing investments, and ensuring compliance with financial regulations across the MENA region. Saad Stephan guides the financial strategy to sustain growth and profitability, particularly in therapeutic areas like infection and central nervous system treatments. The financial oversight provided by Stephan is essential for Tabuk Pharmaceuticals' continued ability to provide quality, affordable medicines.

Hatem Reda - Chief Marketing Officer

Hatem Reda, the Chief Marketing Officer at Tabuk Pharmaceuticals, architects and executes comprehensive marketing strategies to expand market reach within the MENA region. Reda drives brand visibility and product adoption across major therapeutic areas, including GI and diabetes, cardiovascular, and respiratory treatments. This leadership position involves analyzing market trends and identifying opportunities for growth in regulated territories. Hatem Reda oversees the development of promotional campaigns and market access initiatives, ensuring Tabuk Pharmaceuticals' cost-effective, quality products reach target demographics. The marketing efforts directed by Reda are fundamental to reinforcing the company's position as a leading generic pharmaceutical provider.

Explore Leadership Teams in Manufacturing

Promega

Founded in 1978, Promega is a manufacturer of enzymes and other products for biotechnology and molecular biology with a portfolio covering the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity. The company is headquartered in Madison, Wisconsin.

Company Leadership

New England Biola...

Founded in 1974, New England BioLabs is a privately held company that produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology, and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase. The company is headquartered in Ipswitch, Massachusetts.

Company Leadership

Darya-Varia

Soft gelatin capsule products, liquid preparations, medicinal plasters, ointments, and creams are produced at the Gunung Putri Plant. In producing these products, Gunung Putri Plant implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 and ISO 22000:2018 certificates. Meanwhile, sterile injection products and solid preparations in the form of tablets and capsules are produced at the Citeureup Plant. The Citeureup Plant also implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and SNI ISO/IEC 17025:2017 certificates. In running the Toll Manufacturing business, Darya-Varia collaborates with an affiliated company, PT Medifarma Laboratories, at the Cimanggis Depok Plant. The Company has been trusted by local business partners and both for the domestic and international markets for the Export & Toll Manufacturing business and conducts technology transfer, lab and pilot trials, stability studies, procurement of raw materials and packaging, and commercial production of high-quality finished goods. Darya-Varia always ensures the quality and safety of each product, so that all of its products are certified halal. All plant facilities owned by Darya-Varia have implemented the halal guarantee system. Blue Sphere Singapore Pte Ltd (BSSPL) owns 92.13% stake in Darya-Varia. For 45 years, Darya-Varia has continued to progress in providing high quality health facilities. Through the mission of "building a healthier Indonesia for everyone one person at a time", Darya-Varia is always committed to providing a variety of quality products with the right strategy for the health of the Indonesian people. DARYA VARIA

Company Leadership

PT. Inertia Utama

PT. Inertia Utama is a company that works within the pharmaceutical industry. The company is based in Tangerang Selatan, Indonesia.

Company Leadership

Frequently Asked Questions Regarding Tabuk Pharmaceuticals Top Executives and Leadership Team

Who leads Tabuk Pharmaceuticals?

Tabuk Pharmaceuticals is led by Ismail Shehada (Chief Executive Officer), along with executives such as Doaa Bugis (Chief Executive Officer Office Manager) and Saad Stephan (Chief Financial Officer).

Who is part of Tabuk Pharmaceuticals’s executive team?

The executive team of Tabuk Pharmaceuticals includes leaders such as Ismail Shehada (Chief Executive Officer), Doaa Bugis (Chief Executive Officer Office Manager), Saad Stephan (Chief Financial Officer) and other senior executives.

How many executives does Tabuk Pharmaceuticals have?

Tabuk Pharmaceuticals has 4 executives leading key business areas.

What roles are included in Tabuk Pharmaceuticals’s leadership team?

The leadership team of Tabuk Pharmaceuticals includes roles such as Chief Executive Officer, Chief Executive Officer Office Manager, Chief Financial Officer, Chief Marketing Officer.